Thursday, September 24, 2020

Diabetes Medicine Pulled Over Carcinogen Concerns

The Food and Drug Administration has posted the voluntary recall of another metformin—the ninth brand pulled since May. Riomet ER, a Type 2 diabetes medicine marketed by Sun Pharmaceutical, was found in tests to contain too much N-nitrosodimethylamine, a carcinogen, the Miami Herald reports. The recall applies to Lot...

No comments:

Post a Comment